NCT05762900View on ClinicalTrials.gov

Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

October 25, 2022

Primary Completion Date

October 25, 2025

Study Completion Date

October 25, 2030

Conditions
Breast CancerRadiotherapy Side Effect
Interventions
RADIATION

Ultra-fractionated radiation therapy

5.2Gy per fraction for 5 fractions with an integrated boost of 6Gy per fraction.

Trial Locations (1)

100021

RECRUITING

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER